<sentence id="0">Human MHC class II gene transcription directed by the carboxyl terminus of CIITA , one of the defective genes in type II MHC combined immune deficiency .</sentence>
<sentence id="1">Type II major histocompatibility complex combined immune deficiency ( type II MHC CID or bare lymphocyte syndrome ) is a congenital immunodeficiency disease characterized by <scope type="neg" id="0"><cue type="neg" id="0">absent</cue> MHC class II expression</scope> .</sentence>
<sentence id="2">Four distinct complementation groups have been identified .</sentence>
<sentence id="3">Recently , the defective gene in group II type II MHC CID has been isolated and termed CIITA .</sentence>
<sentence id="4">Here , we demonstrate that CIITA is an MHC class II gene-specific transcription activator .</sentence>
<sentence id="5">The transcription activation function is provided by the N-terminal acidic domain ( amino acids 26-137 ) , which is experimentally exchangeable with a heterologous viral transcription-activating domain .</sentence>
<sentence id="6">The specificity of CIITA for three major MHC class II genes , DR , DQ and DP , is mediated by its remaining C-terminal residues ( amino acids 317-1130 ) .</sentence>
<sentence id="7">The transactivation of multiple cis elements , especially S and X2 , of the DR alpha proximal promoter in group II CID cells is CIITA dependent .</sentence>
<sentence id="8">Since CIITA overexpression in normal cells did <scope type="neg" id="1"><cue type="neg" id="1">not</cue> increase class II expression</scope> , we <scope type="spec" id="2"> <cue type="spec" id="2">propose</cue> that initiation of CIITA expression serves as the on-off switch , while availability of downstream interactor(s) limits transcription</scope> .</sentence>